BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33599244)

  • 1. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.
    Oldroyd AGS; Allard AB; Callen JP; Chinoy H; Chung L; Fiorentino D; George MD; Gordon P; Kolstad K; Kurtzman DJB; Machado PM; McHugh NJ; Postolova A; Selva-O'Callaghan A; Schmidt J; Tansley S; Vleugels RA; Werth VP; Aggarwal R
    Rheumatology (Oxford); 2021 Jun; 60(6):2615-2628. PubMed ID: 33599244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease.
    Hannah JR; Law HE; Gordon T; Rooney M; Buazon A; Adas M; Nagra D; Stovin C; Galloway J; Gordon PA
    J Rheumatol; 2023 Mar; 50(3):373-383. PubMed ID: 36379584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohorts.
    Zhong L; Yu Z; Song H
    Clin Immunol; 2019 Jan; 198():11-18. PubMed ID: 30445156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.
    Rigolet A; Musset L; Dubourg O; Maisonobe T; Grenier P; Charuel JL; Behin A; Herson S; Amoura Z; Benveniste O
    Medicine (Baltimore); 2012 Mar; 91(2):95-102. PubMed ID: 22391471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.
    He X; Ji J; Chen X; Luo Z; Fang S; Yan H; Guo L
    Semin Arthritis Rheum; 2024 Feb; 64():152350. PubMed ID: 38086199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies.
    Ríos G
    J Clin Rheumatol; 2005 Jun; 11(3):153-6. PubMed ID: 16357735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Risk and Mortality in Hospitalized Patients With Idiopathic Inflammatory Myopathies in Western Australia.
    Nossent JC; Keen H; Preen D; Inderjeeth C
    J Rheumatol; 2024 Apr; 51(4):396-402. PubMed ID: 38302176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of ischemic stroke in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis.
    Zhen C; Wang Y; Wang H; Wang X
    Clin Rheumatol; 2021 Oct; 40(10):4101-4108. PubMed ID: 33934269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease.
    Cobo-Ibáñez T; López-Longo FJ; Joven B; Carreira PE; Muñoz-Fernández S; Maldonado-Romero V; Larena-Grijalba C; Cubas IL; Muriel ET; Mateos CB; de la Peña Lefebvre PG; Gomez-Gomez A; Nogal LB; Pérez A; Almodovar R; Lojo L; Ruiz-Gutiérrez L; López-Robledillo JC; García de Yébenes MJ; Nuño-Nuño L
    Clin Rheumatol; 2019 Mar; 38(3):803-815. PubMed ID: 30392161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.
    Peng JM; Du B; Wang Q; Weng L; Hu XY; Wu CY; Shi Y
    PLoS One; 2016; 11(4):e0154441. PubMed ID: 27115138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria.
    Didona D; Juratli HA; Scarsella L; Keber U; Eming R; Hertl M
    Eur J Dermatol; 2020 Jun; 30(3):279-288. PubMed ID: 32666928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
    Johnson C; Connors GR; Oaks J; Han S; Truong A; Richardson B; Lechtzin N; Mammen AL; Casciola-Rosen L; Christopher-Stine L; Danoff SK
    Respir Med; 2014 Oct; 108(10):1542-8. PubMed ID: 25269710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort.
    Naveen R; Rathore U; Agarwal V; Gupta L
    Rheumatol Int; 2021 Mar; 41(3):551-563. PubMed ID: 33423071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity.
    Watanabe E; Kato K; Gono T; Chiba E; Terai C; Kotake S
    Rheumatology (Oxford); 2021 Jan; 60(1):322-332. PubMed ID: 32770187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.
    Pleštilová L; Mann H; Andrés Cerezo L; Pecha O; Vencovský J; Šenolt L
    Arthritis Res Ther; 2014 Oct; 16(5):468. PubMed ID: 25359220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies.
    Wong VT; So H; Lam TT; Yip RM
    Acta Neurol Scand; 2021 Feb; 143(2):131-139. PubMed ID: 32762037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.